News

Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX ...
Pain avoidance as a key motivator: Numerous surveys in 2025 indicate that a major reason people avoid consistent health tracking is the pain associated with needles or invasive procedures. As a result ...
The Diabetes Devices Market was valued at US$ 33.4 Billion in 2024 and is projected to reach US$ 64.8 Billion by 2033, growing at a CAGR of 7.7%. The U.S. diabetes devices market is witnessing strong ...
Roche has launched what it says is a first-of-its-kind handheld glucose management device, backed up by a digital platform that aims to simplify the work of doctors and nurses as they deliver care ...
Browse 786 market data Tables and 64 Figures spread through 577 Pages and in-depth TOC on "Point of Care Diagnostics Market ...
Monitoring the level of glucose (sugar) in your blood is vital if you have diabetes. You get results in real time, which allows you to adjust your medications, exercise and food accordingly.
Roche Diabetes Care India on Thursday announced that their blood glucose monitoring device ‘Accu-Chek Active’ is now manufactured in India. This move is a part of the company’s strategy to ...
Suitability: ages 6 years and over with type 1 diabetes Administration: tubing connects the insulin pump to the infusion site and does not require finger sticks when paired with the Dexcom G6 CGM ...
Accu-Chek manufactures four blood glucose meters that people can use to monitor diabetes. Read on to learn more about what features these devices have and when to speak with a doctor.